724
Views
0
CrossRef citations to date
0
Altmetric
Chronic Kidney Disease and Progression

Genetic association between celiac disease and chronic kidney disease: a two-sample Mendelian randomization study

, , &
Article: 2357246 | Received 17 Oct 2023, Accepted 14 May 2024, Published online: 04 Jun 2024

References

  • Catassi C, Verdu EF, Bai JC, et al. Coeliac disease. Lancet. 2022;399(10344):1–10. doi:10.1016/S0140-6736(22)00794-2.
  • Iversen R, Sollid LM. The immunobiology and pathogenesis of celiac disease. Annu Rev Pathol Mech Dis. 2023;18(1):47–70.
  • Pinto-Sanchez MI, Silvester JA, Lebwohl B, et al. Society for the study of celiac disease position statement on gaps and opportunities in coeliac disease. Nat Rev Gastroenterol Hepatol. 2021;18(12):875–884. doi:10.1038/s41575-021-00511-8.
  • Chen Z, Li Y, Yuan Y, et al. Single-cell sequencing reveals homogeneity and heterogeneity of the cytopathological mechanisms in different etiology-induced AKI. Cell Death Dis. 2023;14(5):318. doi:10.1038/s41419-023-05830-z.
  • Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310. doi:10.1001/jamainternmed.2022.6817.
  • Xie Y, Bowe B, Mokdad AH, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567–581.
  • Chen H, Fang Y, Wu J, et al. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD. Cell Death Dis. 2018;9(9):878. doi:10.1038/s41419-018-0936-8.
  • Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735.
  • August P. Chronic kidney disease - Another step forward. N Engl J Med. 2023;388(2):179–180. doi:10.1056/NEJMe2215286.
  • Boonpheng B, Cheungpasitporn W, Wijarnpreecha K. Renal disease in patients with celiac disease. Minerva Med. 2018;109(2):126–140. doi:10.23736/S0026-4806.17.05403-9.
  • Liu L, Khan A, Sanchez-Rodriguez E, et al. Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits. Nat Commun. 2022;13(1):6859. doi:10.1038/s41467-022-34456-6.
  • Nurmi R, Pasternack C, Salmi T, et al. The risk of renal comorbidities in celiac disease patients depends on the phenotype of celiac disease. J Intern Med. 2022;292(5):779–787. doi:10.1111/joim.13532.
  • Sahin I, Eminbeyli L, Andic S, et al. Screening for celiac disease among patients with chronic kidney disease. Ren Fail. 2012;34(5):545–549.
  • Mirza F, Canalis E. Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol. 2015;173(3):R131–R151. doi:10.1530/EJE-15-0118.
  • Lin J, Zhou J, Xu Y. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Brain. 2023;146(8):3364–3372. doi:10.1093/brain/awad070.
  • Leonard MM, Sapone A, Catassi C, et al. Celiac disease and nonceliac gluten sensitivity: a review. JAMA. 2017;318(7):647–656. doi:10.1001/jama.2017.9730.
  • Brown NK, Guandalini S, Semrad C, et al. A clinician’s guide to celiac disease HLA genetics. Am J Gastroenterol. 2019;114(10):1587–1592. doi:10.14309/ajg.0000000000000310.
  • Julian TH, Boddy S, Islam M, et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2022;145(3):832–842. doi:10.1093/brain/awab420.
  • Robinson-Cohen C, Triozzi JL, Rowan B, et al. Genome-wide association study of CKD progression. J Am Soc Nephrol. 2023;34(9):1547–1559.
  • Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925–1926. doi:10.1001/jama.2017.17219.
  • Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43(12):1193–1201. doi:10.1038/ng.998.
  • Dubois PCA, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42(4):295–302. doi:10.1038/ng.543.
  • Pattaro C, Teumer A, Gorski M, et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun. 2016;7(1):10023. doi:10.1038/ncomms10023.
  • Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–314.
  • Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–698. doi:10.1038/s41588-018-0099-7.
  • Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-egger method. Eur J Epidemiol. 2017;32(5):377–389. doi:10.1007/s10654-017-0255-x.
  • Lawlor DA, Harbord RM, Sterne JA, et al. G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–1163.
  • Yuan S, Larsson SC. Coffee and caffeine consumption and risk of kidney stones: a Mendelian randomization study. Am J Kidney Dis. 2022;79(1):9–14. e1.
  • Lian X, Wang Y, Wang S, et al. Does inflammatory bowel disease promote kidney diseases: a Mendelian randomization study with populations of european ancestry. BMC Med Genomics. 2023;16(1):225. doi:10.1186/s12920-023-01644-2.
  • Murray JA, Syage JA, Wu T-T, et al. Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge. Gastroenterology. 2022;163(6):1510–1521.e6. doi:10.1053/j.gastro.2022.07.071.
  • Zoghi S, Abbasi A, Heravi FS, et al. The gut microbiota and celiac disease: pathophysiology, current perspective and new therapeutic approaches. Crit Rev Food Sci Nutr. 2024;64(8):2176–2196.
  • Mozzillo E, Franceschi R, Di Candia F, et al. The impact of gluten-free diet on growth, metabolic control and quality of life in youth with type 1 diabetes and celiac disease: a systematic review. Diabetes Res Clin Pract. 2022;191:110032.
  • Hayek A, Robert AA, Alotaibi AA, et al. Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes. Diabetes Metab Syndr. 2020;14(6):1841–1845.
  • Cabanillas B. Gluten-related disorders: celiac disease, wheat allergy, and nonceliac gluten sensitivity. Crit Rev Food Sci Nutr. 2020;60(15):2606–2621.
  • Chen Z, Lan R, Ye K, et al. Prioritization of diagnostic and prognostic biomarkers for lupus nephritis based on integrated bioinformatics analyses. Front Bioeng Biotechnol. 2021;9:717234. doi:10.3389/fbioe.2021.717234.
  • Säemann M, Kronbichler A. Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors. Ann Rheum Dis. 2022;81(5):614–617. doi:10.1136/annrheumdis-2021-221474.
  • Hershko C, Patz J. Ironing out the mechanism of anemia in celiac disease. Haematologica. 2008;93(12):1761–1765. doi:10.3324/haematol.2008.000828.
  • Zoccali C, Mallamaci F, Adamczak M, et al. Cardiovascular complications in chronic kidney disease: a review from the european renal and cardiovascular medicine working group of the european renal association. Cardiovasc Res. 2023;119(11):2017–2032. doi:10.1093/cvr/cvad083.
  • Aaron L, Torsten M, Patricia W. Autoimmunity in celiac disease: extra-intestinal manifestations. Autoimmun Rev. 2019;18(3):241–246.